• 1. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 2. Fe3O4@PANI: a magnetic polyaniline nanomaterial for highly efficient and handy enrichment of intact N-glycopeptides??
  Zhizhen Lai,Mo Zhang,Jinyu Zhou,Tianjing Chen,Dan Li,Xuejing Shen,Jia Liu,Jiang Zhou,Zhili Li Analyst, 2021,146, 4261-4267
• 3. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726
• 4. Distributed research: a new paradigm for undergraduate research and global problem solving?
  Bruce Parkinson Energy Environ. Sci., 2010,3, 509-511
• 5. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305

Methyl 5-chloro-1H-pyrrolo[2,3-b]pyridine-2-carboxylate (CAS No. 952182-19-3): A Comprehensive Overview

Methyl 5-chloro-1H-pyrrolo[2,3-b]pyridine-2-carboxylate, identified by its CAS number 952182-19-3, is a significant compound in the field of pharmaceutical chemistry and medicinal research. This heterocyclic compound belongs to the pyrrolopyridine class, which has garnered considerable attention due to its diverse biological activities and potential applications in drug development. The structural features of this molecule, particularly the presence of a chloro substituent and a carboxylate group, contribute to its unique chemical properties and reactivity, making it a valuable scaffold for synthetic chemists and biologists alike.

The compound’s molecular structure consists of a fused ring system comprising a pyrrole ring and a pyridine ring, interconnected at the 2 and 3 positions. This bicyclic framework is further modified by the introduction of a 5-chloro group at the 5-position of the pyrrole ring and a 2-carboxylate group at the 2-position of the pyridine ring. Such structural modifications enhance the compound’s interactability with biological targets, making it an attractive candidate for further exploration in medicinal chemistry.

In recent years, there has been growing interest in pyrrolopyridine derivatives due to their demonstrated efficacy in various pharmacological contexts. The Methyl 5-chloro-1H-pyrrolo[2,3-b]pyridine-2-carboxylate has been studied for its potential role in modulating biological pathways associated with inflammation, cancer, and neurodegenerative diseases. Its ability to engage with multiple targets makes it a promising candidate for developing novel therapeutic agents.

One of the most compelling aspects of this compound is its versatility in synthetic chemistry. The presence of both chloro and carboxylate functional groups provides multiple points for chemical modification, allowing researchers to tailor its properties for specific applications. For instance, the carboxylate group can be used to form esters or amides, while the chloro group can undergo nucleophilic substitution reactions to introduce additional substituents. This flexibility has enabled the synthesis of a wide range of derivatives with tailored biological activities.

Recent studies have highlighted the compound’s potential in oncology research. The fused heterocyclic system of Methyl 5-chloro-1H-pyrrolo[2,3-b]pyridine-2-carboxylate has been shown to interact with enzymes and receptors involved in cancer cell proliferation and survival. Preclinical studies have demonstrated that certain derivatives of this compound can inhibit the activity of kinases and other enzymes that are overexpressed in tumor cells. These findings suggest that Methyl 5-chloro-1H-pyrrolo[2,3-b]pyridine-2-carboxylate could serve as a lead compound for developing new anticancer therapies.

The compound’s pharmacokinetic properties have also been investigated as part of its development as a potential drug candidate. Studies have shown that it exhibits good solubility in both water and organic solvents, which is advantageous for formulating it into various dosage forms. Additionally, preliminary toxicity studies have indicated that it is well-tolerated at moderate doses, suggesting a favorable safety profile. However, further extensive studies are required to fully understand its long-term effects and potential side effects.

In addition to its applications in oncology, Methyl 5-chloro-1H-pyrrolo[2,3-b]pyridine-2-carboxylate has shown promise in other therapeutic areas. Research has indicated that it may have anti-inflammatory properties by modulating cytokine production and inhibiting inflammatory pathways. This makes it a potential candidate for developing treatments for chronic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

The synthesis of Methyl 5-chloro-1H-pyrrolo[2,3-b]pyridine-2-carboxylate involves multi-step organic reactions that showcase the expertise of synthetic chemists. The process typically begins with the formation of the pyrrolopyridine core through cyclization reactions followed by functional group modifications to introduce the chloro and carboxylate groups. Advanced techniques such as palladium-catalyzed cross-coupling reactions have been employed to achieve high yields and purity levels.

The compound’s role in drug discovery extends beyond its direct use as a therapeutic agent. It serves as an important intermediate in the synthesis of more complex molecules with enhanced biological activity. Researchers often use Methyl 5-chloro-1H-pyrrolo[2,3-b]pyridine-2-carboxylate as a building block to create novel scaffolds that can be optimized for specific pharmacological targets.

The growing body of research on Methyl 5-chloro-1H-pyrrolo[2,3-b]pyridine-2-carboxylate underscores its significance in modern pharmaceutical chemistry. As our understanding of biological pathways continues to evolve, compounds like this one will play an increasingly important role in developing innovative treatments for various diseases. The combination of its structural versatility and demonstrated biological activity makes it a cornerstone in ongoing drug development efforts.

• 394223-02-0(Methyl 1H-pyrrolo[2,3-b]pyridine-2-carboxylate)
• 132308-19-1(Methyl 5-chloropyridine-2-carboxylate)
• 1256825-86-1(Methyl 1H-pyrrolo[2,3-b]pyridine-6-carboxylate)
• 1204475-99-9(1H-Pyrrolo[2,3-b]pyridine-2-carboxylic acid, 3-chloro-, methyl ester)
• 221675-35-0(Ethyl 1H-pyrrolo[2,3-b]pyridine-2-carboxylate)
• 1196151-72-0(Ethyl 4-chloro-1H-pyrrolo[2,3-b]pyridine-2-carboxylate)
• 1083181-28-5(Ethyl 5-chloro-1H-pyrrolo[2,3-b]pyridine-2-carboxylate)
• 871583-23-2(Methyl 4-chloro-1H-pyrrolo[2,3-b]pyridine-2-carboxylate)
• 800401-84-7(5-Chloro-1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid)
• 1140512-58-8(Methyl 6-chloro-1H-pyrrolo[2,3-b]pyridine-2-carboxylate)